Latest Close
$2.67
News
EDIT
Editas Medicine, Inc. News
This news view pulls recent coverage and headlines tied to EDIT.
1y Change
$1.55 (+138.39%)
Market Cap
$261,318,240.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
GlobeNewswire • Mar 27, 2026
Read articleIs Editas Medicine Going to $0?
Motley Fool • Mar 17, 2026
Read articleEditas Medicine Details In Vivo CRISPR Plan, Targets Year-End Human Proof-of-Concept for EDIT-401
MarketBeat • Mar 15, 2026
Read articleEDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y
Zacks • Mar 10, 2026
Read articleMedicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
ACCESS Newswire • Mar 10, 2026
Read articleEditas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
Zacks • Mar 9, 2026
Read article